PACT调控细胞迁移的分子机制

基本信息
批准号:31701217
项目类别:青年科学基金项目
资助金额:23.00
负责人:韦璐瑶
学科分类:
依托单位:上海中医药大学
批准年份:2017
结题年份:2020
起止时间:2018-01-01 - 2020-12-31
项目状态: 已结题
项目参与者:丁涵青,袁琳,车芸华,高宇宏,曹志伟
关键词:
细胞迁移(cellUbc9migration)细胞骨架(cytoskeleton)PACT
结项摘要

Interferon-inducible double-stranded RNA-dependent protein kinase activator A (PACT) is a dsRNA-associating protein, and its deficiency can lead to malfunction in neuronal development. SNPs in PACT gene is associated with worse survival in colon cancer, and colon cancer at advanced stages showed higher PACT level than earlier stages. However, the detailed molecular mechanism is still largely unknown. We have found that PACT knock-down in post-natal day (PD) 4 could significantly inhibit cerebella granule neurons (CGNs) migration, further experiments on cell lines confirm the role PACT played in regulation of migration. Importantly, by virtue of Tandem Affinity Purification and Mass Spectrometry we identified Ubc9 as an interaction partner of PACT. Overexpression of Ubc9 efficiently rescued inhibition of Cell migration caused by knock-down of of PACT, implying that Ubc9 is involved in PACT-regulated cell migration. In this project, we will firstly investigate whether the regulatory effect of PACT-Ubc9 complex on cell migration is based on its regulation of cell skeleton. If so, we will further identify other proteins residing downstream of PACT-Ubc9 complex and involved in the regulation of cell skeleton and migration. Taken together, we would eventually elucidate the molecular mechanism by which PACT regulates migration. Our results may provide clues for the therapy of migration relevant diseases.

干扰素诱导双链RNA依赖蛋白激活蛋白PACT是一个双链RNA结合蛋白。研究表明PACT缺失引起神经系统发育不良,PACT的基因单核苷酸多态性与结肠癌较差的预后相关,且结肠癌病人组织芯片中,PACT蛋白水平上调 。我们前期研究发现敲低新生小鼠颗粒细胞前体中的PACT抑制细胞迁移, 继而验证了在细胞系中,PACT对细胞迁移的调控也同样适用。运用亲和纯化加质谱技术我们发现Ubc9(为SUMO结合酶E2)能够与PACT相互作用,且过量表达Ubc9能够缓解PACT敲低引发的细胞迁移抑制。本课题将首先确定PACT-Ubc9复合体是否通过调节细胞骨架影响细胞迁移, 进而鉴定参与该复合体调控细胞骨架的其它蛋白,阐明其相互调节关系,最终揭示PACT调控细胞迁移的分子机制。本研究有望为细胞迁移相关疾病的治疗提供新的思路。

项目摘要

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

奥希替尼治疗非小细胞肺癌患者的耐药机制研究进展

奥希替尼治疗非小细胞肺癌患者的耐药机制研究进展

DOI:
发表时间:2020
2

长链基因间非编码RNA 00681竞争性结合miR-16促进黑素瘤细胞侵袭和迁移

长链基因间非编码RNA 00681竞争性结合miR-16促进黑素瘤细胞侵袭和迁移

DOI:
发表时间:2021
3

TRPV1/SIRT1介导吴茱萸次碱抗Ang Ⅱ诱导的血管平滑肌细胞衰老

TRPV1/SIRT1介导吴茱萸次碱抗Ang Ⅱ诱导的血管平滑肌细胞衰老

DOI:10.3969/j.issn.1001-1978.2022.02.019
发表时间:2022
4

Low level of 5-Hydroxymethylcytosine predicts poor prognosis in non-small cell lung cancer

Low level of 5-Hydroxymethylcytosine predicts poor prognosis in non-small cell lung cancer

DOI:10.3892/ol.2016.4474
发表时间:2016
5

血管内皮细胞线粒体动力学相关功能与心血管疾病关系的研究进展

血管内皮细胞线粒体动力学相关功能与心血管疾病关系的研究进展

DOI:10.13191/j.chj.2017.0028
发表时间:2016

韦璐瑶的其他基金

相似国自然基金

1

利用基因敲除小鼠模型研究p53负调控分子PACT的生理功能及调控机制

批准号:30771073
批准年份:2007
负责人:田春艳
学科分类:C0704
资助金额:28.00
项目类别:面上项目
2

Supervillin(SVIL)调控细胞迁移与侵袭的分子机制研究

批准号:31571433
批准年份:2015
负责人:方志友
学科分类:C0706
资助金额:60.00
项目类别:面上项目
3

RhoA信号通路对创伤皮肤表皮细胞迁移的分子调控机制

批准号:30973129
批准年份:2009
负责人:张琳
学科分类:H1703
资助金额:31.00
项目类别:面上项目
4

CD74调控乳腺癌细胞迁移的分子机制

批准号:81472686
批准年份:2014
负责人:苏玲
学科分类:H1809
资助金额:80.00
项目类别:面上项目